Skip to main content


Transdisciplinary Global Research in Rare CNS Tumors: A Framework to Impact Outcomes Across CNS Disease

Register now for a complimentary four-hour virtual course on the challenges of clinical care and research in rare CNS tumors and a discussion of possible solutions to improve outcomes

September 25, 2020 
11:00am – 3:00pm ET (US)

Register for Course

This course is a collaborative effort of the Society for Neuro-Oncology; National Cancer Institute, National Institutes of Health; Erasmus MC Cancer Institute; Yale University and Brigham and Women's Hospital; Piedmont Healthcare; Cambridge Cancer Center; CRUK Cambridge Institute; Fred Hutchinson Cancer Research Center; and Heidelberg University Hospital, The Jackson Laboratory. Registration is free and limited to the first 1,000 participants. The target audience is health care providers who care for people with central nervous system tumors. All SNO webinars are recorded, so if you miss one, you will be able to view it on-demand on SNO’s Online Education Center. 

The overall learning goal is to increase awareness about the challenges of clinical care and research in CNS tumors and possible solutions.

By the end of this course, participants will be able to:

  1. List challenges in creating preclinical models for CNS tumors that reliably recapitulate human disease.
  2. List novel techniques in CNS tumor classification and their prognostic and/or therapeutic implications.
  3. Identify challenges in clinical trial design and describe innovative methods applicable to patients with rare CNS tumors.
  4. List ongoing initiatives to improve care and enhance research for patients with rare CNS tumors.
Transdisciplinary Global Research in Rare CNS Tumors Program

Kenneth Aldape, MD
Chief and Senior Investigator
National Cancer Institute, NIH

Terri Armstrong, PhD
Deputy Chief and Senior Investigator
National Cancer Institute, NIH

Martin van den Bent, MD, PhD
Professor and Head of Neuro-Oncology
Erasmus MC Cancer Institute

Elizabeth B. Claus, MD, PhD
Professor of Biostatistics and Neurosurgery, Yale University
Attending Neurosurgeon and Director of Stereotactic Radiosurgery, Department of Neurosurgery, Brigham and Women's Hospital

Erin Dunbar, MD
Director of Neuro-Oncology
Brain Tumor Center, Piedmont Healthcare

Mark Gilbert, MD
Chief, Senior Investigator and CCR Deputy Director
National Cancer Institute, NIH

Richard Gilbertson, PhD
University of Cambridge
Li Ka Shing Chair of Oncology
Head of Department of Oncology
Cancer Research UK Cambridge Centre

Eric Holland, MD, PhD
Senior Vice President and Director, Human Biology Division
Fred Hutchinson Cancer Research Center and University of Washington School of Medicine

Marta Penas-Prado, MD
Associate Research Physician
National Cancer Institute, NIH

Felix Sahm, MD, PhD
Managing Senior Physician, Neuropathology
Heidelberg University Hospital

Roel Verhaak, PhD
Professor and Associate Director of Computational Biology
The Jackson Laboratory